We are live on ! Find out more
AIA

AIMZ Investment Advisors Portfolio holdings

AUM $363M
1-Year Est. Return 29.68%
This Fund
S&P 500
This Quarter Est. Return
+16.78%
1 Year Est. Return
+29.68%
3 Year Est. Return
+81.32%
5 Year Est. Return
+101.59%
10 Year Est. Return
+396.9%
AUM
$363M
AUM Growth
+$39.9M
Cap. Flow
+$6.73M
Cap. Flow %
1.85%
Top 10 Hldgs %
33.9%
Holding
156
New
17
Increased
22
Reduced
62
Closed
3

Top Buys

Rank Stock Value
1
ZTS icon
Zoetis
ZTS
+$4.63M
2
JKHY icon
Jack Henry & Associates
JKHY
+$2.46M
3
MU icon
Micron Technology
MU
+$469K
4
TXN icon
Texas Instruments
TXN
+$275K
5
GLW icon
Corning
GLW
+$255K

Top Sells

Rank Stock Value
1
SPGI icon
S&P Global
SPGI
+$1.25M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$429K
3
NVDA icon
NVIDIA
NVDA
+$350K
4
ADI icon
Analog Devices
ADI
+$340K
5
HON icon
Honeywell
HON
+$287K

Sector Composition

Rank Sector Weight
1 Technology 32.55%
2 Healthcare 25.21%
3 Communication Services 12.28%
4 Industrials 8.46%
5 Miscellaneous 7.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AAPL icon
1
Apple
AAPL
$4.68T
$25.9M 7.14%
89,665
-955
-1% -$273K
GOOGL icon
2
Alphabet (Google) Class A
GOOGL
$4.13T
$15M 4.13%
41,959
-308
-0.7% -$111K
META icon
3
Meta Platforms (Facebook)
META
$1.55T
$14.1M 3.88%
25,024
– –
GOOG icon
4
Alphabet (Google) Class C
GOOG
$4.09T
$13.6M 3.75%
38,527
-1,200
-3% -$429K
MSFT icon
5
Microsoft
MSFT
$3.73T
$10.4M 2.86%
27,896
-50
-0.2% -$20.2K
QCOM icon
6
Qualcomm
QCOM
$182B
$10.3M 2.84%
55,840
-97
-0.2% -$18.1K
VRTX icon
7
Vertex Pharmaceuticals
VRTX
$140B
$9.9M 2.72%
19,931
-25
-0.1% -$11.1K
NTAP icon
8
NetApp
NTAP
$36.9B
$8.52M 2.34%
55,037
+3
+0% +$392
GILD icon
9
Gilead Sciences
GILD
$186B
$7.75M 2.13%
61,319
-19
-0% -$2.5K
CSCO icon
10
Cisco
CSCO
$432B
$7.7M 2.12%
65,557
-271
-0.4% -$28.3K
CHRW icon
11
C.H. Robinson
CHRW
$17B
$7.56M 2.08%
40,129
-327
-0.8% -$58.1K
INCY icon
12
Incyte
INCY
$25.7B
$7.38M 2.03%
65,133
-25
-0% -$2.48K
TEVA icon
13
Teva Pharmaceuticals
TEVA
$42.7B
$7.22M 1.99%
212,978
-2,000
-0.9% -$66.6K
UNH icon
14
UnitedHealth
UNH
$358B
$6.3M 1.73%
15,160
+1
+0% +$371
EXPD icon
15
Expeditors International
EXPD
$24.5B
$6.05M 1.66%
37,106
-297
-0.8% -$45.9K
REGN icon
16
Regeneron Pharmaceuticals
REGN
$86.3B
$5.92M 1.63%
9,491
– –
TROW icon
17
T. Rowe Price
TROW
$23.4B
$5.49M 1.51%
48,258
-20
-0% -$2.04K
WMT icon
18
Walmart Inc
WMT
$856B
$5.2M 1.43%
45,895
-209
-0.5% -$25.9K
BRK.B icon
19
Berkshire Hathaway Class B
BRK.B
$1.08T
$5.19M 1.43%
10,378
– –
AZN icon
20
AstraZeneca
AZN
$252B
$5.16M 1.42%
27,221
-75
-0.3% -$14.1K
IBM icon
21
IBM
IBM
$220B
$4.99M 1.37%
17,733
+2
+0% +$504
AMGN icon
22
Amgen
AMGN
$237B
$4.68M 1.29%
12,935
+51
+0.4% +$17.5K
EEFT icon
23
Euronet Worldwide
EEFT
$2.74B
$4.51M 1.24%
61,636
+200
+0.3% +$14K
GMAB icon
24
Genmab
GMAB
$20.8B
$4.42M 1.22%
160,910
– –
CTAS icon
25
Cintas
CTAS
$79.8B
$4.24M 1.17%
24,933
– –
1
2 3 4 5

Similar funds

GC
GFG Capital Miami, Florida $363M AUM 45.53% 1-Year Est. Return
RWP
Reliant Wealth Planning Louisville, Kentucky $364M AUM 11.96% 1-Year Est. Return
GCM
Glynn Capital Management Menlo Park, California $363M AUM 65.91% 1-Year Est. Return
TFG
Tilson Financial Group New Providence, New Jersey $364M AUM 16.66% 1-Year Est. Return
ECA
Elevated Capital Advisors Sandy, Utah $364M AUM 17.23% 1-Year Est. Return
RBCM
Raub Brock Capital Management Larkspur, California $363M AUM 12.74% 1-Year Est. Return
PWM
Purus Wealth Management Newport Beach, California $363M AUM 39.16% 1-Year Est. Return
SFMG
Sage Financial Management Group Mclean, Virginia $364M AUM 15.61% 1-Year Est. Return

AIMZ Investment Advisors's Q2 2026 Portfolio in Review

As of Q2 2026, AIMZ Investment Advisors held 156 positions worth $363M, up 12% from $324M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

AIMZ Investment Advisors's Q2 2026 filing shows 17 new, 22 increased, 62 reduced and 3 closed positions. Its largest new stake was Zoetis: 49,190 shares worth $3.53M. The largest sale was S&P Global, an estimated $1.25M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 30% a quarter earlier, followed by Healthcare and Communication Services.

  • AIMZ Investment Advisors's largest Q2 2026 buy was Zoetis: 49,190 shares worth $3.53M.
  • AIMZ Investment Advisors added most to Eli Lilly in Q2 2026, an estimated $76.6K increase.
  • AIMZ Investment Advisors's biggest Q2 2026 reduction was Alphabet (Google) Class C, cutting an estimated $429K.
  • AIMZ Investment Advisors fully exited S&P Global in Q2 2026, selling an estimated $1.25M.
  • AIMZ Investment Advisors's ten largest holdings make up 34% of its $363M portfolio in Q2 2026.
  • AIMZ Investment Advisors opened 17 new positions and closed 3 in Q2 2026.
  • AIMZ Investment Advisors's portfolio value rose 12% quarter-over-quarter to $363M.

Based on AIMZ Investment Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.